Coverage on Hippo begins with Keefe, Bruyette & Woods.
According to The Fly, Goldman Sachs Group has confirmed that it will maintain its “neutral” rating ...
Read moreAccording to The Fly, Goldman Sachs Group has confirmed that it will maintain its “neutral” rating ...
Read moreEquities research analysts at Guggenheim began coverage on shares of Century Therapeutics (NASDAQ:IPSC - Get Rating) ...
Read moreEquities research analysts at StockNews.com initiated coverage on shares of Zions Bancorporation, National Association (NASDAQ:ZION - ...
Read moreAs Wall Street is reeling under the evolving geopolitical situation, Fed’s rate hikes and high inflation ...
Read moreInvestment experts at Bloomberg reportedly obtained coverage of First United in a report that was made ...
Read morenaphtalina/iStock via Getty Images Biopharmaceutical companies Athira Pharma (ATHA) and BioXcel Therapeutics (BTAI) outperformed the gains ...
Read moreEver since Medicare proposed to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency ...
Read moreAwakn Life Sciences AWKNF is in the news after a respected analyst has upgraded the stock. Awakn ...
Read moreStockNews.com assumed coverage on shares of Woodward (NASDAQ:WWD - Get Rating) in a research note issued ...
Read moreThe F.D.A. also required Biogen to conduct another clinical trial to determine if the drug provided ...
Read more© 2022 TheDailyStock.News